C

CASI Pharmaceuticals Inc
NASDAQ:CASI

Watchlist Manager
CASI Pharmaceuticals Inc
NASDAQ:CASI
Watchlist
Price: 5.55 USD -0.89% Market Closed
Market Cap: 74.4m USD
Have any thoughts about
CASI Pharmaceuticals Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
CASI Pharmaceuticals Inc

Current Assets 59.3m
Cash & Short-Term Investments 18.8m
Receivables 10.1m
Other Current Assets 30.4m
Non-Current Assets 15.9m
Long-Term Investments 1.7m
PP&E 11.6m
Intangibles 1.8m
Other Non-Current Assets 766k
Current Liabilities 16.7m
Accounts Payable 4.4m
Accrued Liabilities 12.3m
Non-Current Liabilities 34.4m
Long-Term Debt 18.9m
Other Non-Current Liabilities 15.5m

Balance Sheet
CASI Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
11
5
27
44
84
54
57
39
47
17
Cash Equivalents
11
5
27
44
84
54
57
39
47
17
Short-Term Investments
0
0
0
0
1
1
9
10
3
2
Total Receivables
0
0
0
0
0
1
5
10
13
10
Accounts Receivables
0
0
0
0
0
1
5
10
13
10
Other Receivables
0
0
0
0
0
0
0
0
0
1
Inventory
0
0
0
0
0
5
1
2
6
16
Other Current Assets
0
0
0
0
7
1
2
2
5
15
Total Current Assets
11
6
27
44
93
62
74
62
73
59
PP&E Net
0
0
0
1
2
10
11
22
13
12
PP&E Gross
0
0
0
0
0
10
11
22
13
12
Accumulated Depreciation
0
0
0
0
0
1
2
2
2
5
Intangible Assets
0
0
0
0
19
17
13
12
1
2
Long-Term Investments
0
0
0
0
0
14
29
40
4
2
Other Long-Term Assets
0
0
0
0
0
1
0
2
4
1
Total Assets
11
N/A
6
-49%
28
+378%
45
+63%
113
+151%
103
-10%
128
+24%
138
+8%
96
-30%
75
-22%
Liabilities
Accounts Payable
1
1
1
4
1
5
4
5
3
4
Accrued Liabilities
0
0
0
1
1
3
3
8
12
12
Short-Term Debt
0
0
0
0
2
0
1
0
0
0
Other Current Liabilities
0
0
0
0
0
0
0
0
2
0
Total Current Liabilities
1
1
1
5
4
8
8
13
17
17
Long-Term Debt
1
2
2
2
0
0
0
0
0
19
Minority Interest
0
0
0
0
0
21
22
24
22
0
Other Liabilities
9
9
4
0
0
1
16
17
12
15
Total Liabilities
12
N/A
12
+2%
7
-42%
7
-4%
4
-41%
30
+659%
46
+56%
54
+16%
52
-4%
51
-1%
Equity
Common Stock
0
0
1
1
1
1
1
1
0
0
Retained Earnings
425
433
442
453
479
524
571
606
637
661
Additional Paid In Capital
433
434
470
499
597
607
658
695
692
696
Treasury Stock
8
8
8
8
8
8
8
8
9
10
Other Equity
0
0
0
0
1
3
1
2
1
1
Total Equity
0
N/A
6
-1 425%
21
N/A
39
+85%
110
+184%
73
-33%
82
+12%
85
+4%
45
-47%
24
-46%
Total Liabilities & Equity
11
N/A
6
-49%
28
+378%
45
+63%
113
+151%
103
-10%
128
+24%
138
+8%
96
-30%
75
-22%
Shares Outstanding
Common Shares Outstanding
3
3
6
7
10
10
12
14
14
13
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0

See Also

Discover More